vs
Side-by-side financial comparison of LIFECORE BIOMEDICAL, INC. \DE\ (LFCR) and First Western Financial Inc (MYFW). Click either name above to swap in a different company.
LIFECORE BIOMEDICAL, INC. \DE\ is the larger business by last-quarter revenue ($31.1M vs $27.5M, roughly 1.1× First Western Financial Inc). Over the past eight quarters, First Western Financial Inc's revenue compounded faster (10.0% CAGR vs -0.1%).
LIFECORE BIOMEDICAL, INC. is a biomedical firm focused on developing and manufacturing high-quality hyaluronic acid-based biomaterials. It operates three core segments: medical application products, pharmaceutical solutions, and personal care ingredients, with main markets spanning North America, Europe and the Asia-Pacific, supplying to leading medical device, pharmaceutical and cosmetic brand partners.
The Western Union Company is an American multinational financial services corporation headquartered in Denver, Colorado.
LFCR vs MYFW — Head-to-Head
Income Statement — Q2 FY2026 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $31.1M | $27.5M |
| Net Profit | $-10.0M | — |
| Gross Margin | 25.0% | — |
| Operating Margin | -9.9% | — |
| Net Margin | -32.1% | — |
| Revenue YoY | -4.5% | — |
| Net Profit YoY | -52.0% | — |
| EPS (diluted) | $-0.29 | $0.63 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | — | $27.5M | ||
| Q4 25 | — | $26.7M | ||
| Q3 25 | $31.1M | $26.3M | ||
| Q2 25 | — | $24.2M | ||
| Q1 25 | $35.2M | $24.8M | ||
| Q4 24 | $32.6M | $24.3M | ||
| Q3 24 | $24.7M | $22.5M | ||
| Q2 24 | — | $22.8M |
| Q1 26 | — | — | ||
| Q4 25 | — | $3.3M | ||
| Q3 25 | $-10.0M | $3.2M | ||
| Q2 25 | — | $2.5M | ||
| Q1 25 | $-14.8M | $4.2M | ||
| Q4 24 | $-6.6M | $2.7M | ||
| Q3 24 | $-16.2M | $2.1M | ||
| Q2 24 | — | $1.1M |
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | 25.0% | — | ||
| Q2 25 | — | — | ||
| Q1 25 | 28.0% | — | ||
| Q4 24 | 34.0% | — | ||
| Q3 24 | 21.8% | — | ||
| Q2 24 | — | — |
| Q1 26 | — | — | ||
| Q4 25 | — | 16.6% | ||
| Q3 25 | -9.9% | 15.1% | ||
| Q2 25 | — | 13.7% | ||
| Q1 25 | -25.7% | 21.6% | ||
| Q4 24 | -6.0% | 16.1% | ||
| Q3 24 | -46.9% | 11.9% | ||
| Q2 24 | — | 6.2% |
| Q1 26 | — | — | ||
| Q4 25 | — | 12.9% | ||
| Q3 25 | -32.1% | 12.1% | ||
| Q2 25 | — | 10.3% | ||
| Q1 25 | -42.0% | 16.9% | ||
| Q4 24 | -20.2% | 11.3% | ||
| Q3 24 | -65.7% | 9.5% | ||
| Q2 24 | — | 4.7% |
| Q1 26 | — | $0.63 | ||
| Q4 25 | — | $0.33 | ||
| Q3 25 | $-0.29 | $0.32 | ||
| Q2 25 | — | $0.26 | ||
| Q1 25 | $-0.47 | $0.43 | ||
| Q4 24 | $-0.25 | $0.28 | ||
| Q3 24 | $-0.53 | $0.22 | ||
| Q2 24 | — | $0.11 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $18.9M | — |
| Total DebtLower is stronger | $136.0M | — |
| Stockholders' EquityBook value | $-10.5M | $273.4M |
| Total Assets | $235.2M | $3.2B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | $18.9M | — | ||
| Q2 25 | — | — | ||
| Q1 25 | $5.4M | — | ||
| Q4 24 | $9.5M | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | $136.0M | — | ||
| Q2 25 | — | — | ||
| Q1 25 | $124.9M | — | ||
| Q4 24 | $111.3M | $0 | ||
| Q3 24 | $106.3M | — | ||
| Q2 24 | — | — |
| Q1 26 | — | $273.4M | ||
| Q4 25 | — | $265.6M | ||
| Q3 25 | $-10.5M | $261.5M | ||
| Q2 25 | — | $258.8M | ||
| Q1 25 | $2.2M | $256.6M | ||
| Q4 24 | $15.4M | $252.3M | ||
| Q3 24 | $-3.9M | $248.8M | ||
| Q2 24 | — | $246.9M |
| Q1 26 | — | $3.2B | ||
| Q4 25 | — | $3.2B | ||
| Q3 25 | $235.2M | $3.2B | ||
| Q2 25 | — | $3.0B | ||
| Q1 25 | $237.7M | $2.9B | ||
| Q4 24 | $255.4M | $2.9B | ||
| Q3 24 | $246.8M | $2.9B | ||
| Q2 24 | — | $2.9B |
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | 56.05× | — | ||
| Q4 24 | 7.20× | 0.00× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $1.8M | — |
| Free Cash FlowOCF − Capex | $25.0K | — |
| FCF MarginFCF / Revenue | 0.1% | — |
| Capex IntensityCapex / Revenue | 5.6% | — |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $-16.8M | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | — | $-1.8M | ||
| Q3 25 | $1.8M | $10.0M | ||
| Q2 25 | — | $-9.1M | ||
| Q1 25 | $1.2M | $8.0M | ||
| Q4 24 | $-6.1M | $606.0K | ||
| Q3 24 | $-613.0K | $18.8M | ||
| Q2 24 | — | $-11.5M |
| Q1 26 | — | — | ||
| Q4 25 | — | $-5.8M | ||
| Q3 25 | $25.0K | $9.0M | ||
| Q2 25 | — | $-9.7M | ||
| Q1 25 | $-4.3M | $7.0M | ||
| Q4 24 | $-8.6M | $-607.0K | ||
| Q3 24 | $-4.0M | $18.6M | ||
| Q2 24 | — | $-11.9M |
| Q1 26 | — | — | ||
| Q4 25 | — | -21.6% | ||
| Q3 25 | 0.1% | 34.1% | ||
| Q2 25 | — | -39.9% | ||
| Q1 25 | -12.1% | 28.1% | ||
| Q4 24 | -26.3% | -2.5% | ||
| Q3 24 | -16.3% | 82.3% | ||
| Q2 24 | — | -52.1% |
| Q1 26 | — | — | ||
| Q4 25 | — | 14.9% | ||
| Q3 25 | 5.6% | 4.1% | ||
| Q2 25 | — | 2.4% | ||
| Q1 25 | 15.5% | 4.2% | ||
| Q4 24 | 7.5% | 5.0% | ||
| Q3 24 | 13.9% | 1.3% | ||
| Q2 24 | — | 1.6% |
| Q1 26 | — | — | ||
| Q4 25 | — | -0.54× | ||
| Q3 25 | — | 3.15× | ||
| Q2 25 | — | -3.63× | ||
| Q1 25 | — | 1.91× | ||
| Q4 24 | — | 0.22× | ||
| Q3 24 | — | 8.83× | ||
| Q2 24 | — | -10.68× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
LFCR
| Transferred At Point In Time | $26.6M | 85% |
| Transferred Over Time | $4.5M | 15% |
MYFW
| Net Interest Income | $20.9M | 76% |
| Noninterest Income | $6.7M | 24% |
